Investors in Edwards Lifesciences Corporation Notified of Class Action Lawsuit

RADNOR, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- The law firm Kessler Topaz Meltzer & Check, LLP has alerted investors about a securities class action lawsuit filed in the United States District Court for the Central District of California against Edwards Lifesciences Corporation ("Edwards"). This lawsuit concerns investors who bought or acquired Edwards securities from February 6, 2024, to July 24, 2024, inclusive (the "Class Period"). The deadline for lead plaintiffs to come forward is December 13, 2024.

For more information, you can reach attorney Jonathan Naji, Esq. by phone at (484) 270-1453 or through email at [email protected].

ALLEGATIONS AGAINST DEFENDANTS:

The lawsuit claims that during the Class Period, the Defendants made misleadingly positive statements about the growth of the company’s main product, the Transcatheter Aortic Valve Replacement ("TAVR"). These claims were allegedly based on false premises, as they concealed critical issues surrounding the actual performance and reception of the TAVR platform. It is alleged that Edwards underestimated the market dynamics and overestimated the commitment from hospitals to the TAVR procedures, especially in light of advancing treatment alternatives.

For more details, you may CLICK HERE to view a related video or access it via this link: YouTube Video.

LEAD PLAINTIFF PROCESS:

Investors in Edwards Lifesciences have until December 13, 2024 to seek appointment as lead plaintiffs through Kessler Topaz Meltzer & Check, LLP or other legal representatives. Lead plaintiffs will act on behalf of all class members throughout the litigation. Typically, the lead plaintiff is the investor or group of investors with the greatest financial interest in the case while also being representative of the broader class. Those who choose not to step forward will remain unnamed members of the class. Importantly, whether or not a person decides to take on the lead plaintiff role does not affect their rights to any potential recovery.

Kessler Topaz Meltzer & Check, LLP actively encourages investors in Edwards Lifesciences who have sustained significant losses to reach out directly for additional information.

ABOUT THE FIRM:

Kessler Topaz Meltzer & Check, LLP is a legal firm that pursues class actions across both federal and state courts in the United States and internationally. The firm has earned a significant reputation for its effective litigation strategies, recovering billions for victims affected by fraudulent practices and corporate misconduct. Their core mission is to safeguard investors, consumers, employees, and others from fraud and corporate negligence. Please note, the firm did not file the complaint in this case. More details about their services can be found on their website.

CONTACT INFORMATION:

Kessler Topaz Meltzer & Check, LLP

Jonathan Naji, Esq.

(484) 270-1453

280 King of Prussia Road

Radnor, PA 19087

[email protected]

This may be considered attorney advertising in specific jurisdictions. Previous results are not indicative of future outcomes.

investors, lawsuit, Edwards